Imaging Steps of Lymphatic Metastasis Reveals That Vascular Endothelial Growth Factor-C Increases Metastasis by Increasing Delivery of Cancer Cells to Lymph Nodes: Therapeutic Implications
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Preclinical and clinical studies positively correlate the expression of vascular endothelial growth factor (VEGF)-C in tumors and the incidence of lymph node metastases. However, how VEGF-C regulates individual steps in the transport of tumor cells from the primary tumor to the draining lymph nodes is poorly understood. Here, we image and quantify these steps in tumors growing in the tip of the mouse ear using intravital microscopy of the draining lymphatic vessels and lymph node, which receives spontaneously shed tumor cells. We show that VEGF-C overexpression in cancer cells induces hyperplasia in peritumor lymphatic vessels and increases the volumetric flow rate in lymphatics at the base of the ear by 40%. The increases in lymph flow rate and peritumor lymphatic surface area enhance the rate of tumor cell delivery to lymph nodes, leading to a 200-fold increase in cancer cell accumulation in the lymph node and a 4-fold increase in lymph node metastasis. In our model, VEGF-C overexpression does not confer any survival or growth advantage on cancer cells. We also show that an anti-VEGF receptor (VEGFR)-3 antibody reduces both lymphatic hyperplasia and the delivery of tumor cells to the draining lymph node, leading to a reduction in lymph node metastasis. However, this treatment is unable to prevent the growth of tumor cells already seeded in lymph nodes. Collectively, our results indicate that VEGF-C facilitates lymphatic metastasis by increasing the delivery of cancer cells to lymph nodes and therapies directed against VEGF-C/VEGFR-3 signaling target the initial steps of lymphatic metastasis. (Cancer Res 2006; 66(16): 8065-75)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“fluid leaking out of a tumour, owing to insufficient drainage via the defective intratumoural lymphatic system, can carry cancer cells to nearby peri-tumour lymphatic vessels, thereby promoting lymphatic metastasis11”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [11]
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733 · cited 1×
“VEGFR-3 signaling is primarily responsible for the lymphangiogenic response to VEGF-C stimulation (19) and leads to lymphangiogenesis and lymphatic hyperplasia in mouse tumor models (11, 14, 15, 20, 21).”
BackgroundDissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281 · cited 1×
“These steps include detachment from the primary tumor mass, invasion into lymphatic vessels, transport through draining lymphatic vessels, arrest in lymph nodes, and survival and growth in lymph nodes (1, 2).”
BackgroundVEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246 · cited 1×
“Interfering with the VEGF-C/VEGFR-3 signaling pathway has been suggested as a useful clinical strategy in the treatment of lymphatic metastasis (13, 27, 28, 41, 42).”
MethodLessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039 · cited 1×
“Thus, a potentially promising strategy to control both hematogenous and lymphatic metastasis would be to block both VEGFR-2 and VEGFR-3 signaling using multitargeted tyrosine kinase inhibitors already approved or in clinical trials (47).”
BackgroundSelf-citationVascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Mandriota, S. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.672 · Cited by 978
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967 · cited 4×
“We showed previously that these VEGF-C-overexpressing cells do not exhibit increased cell migration (14).”
BackgroundResultInfluentialSelf-citationIntravital imaging of cell movement in tumours
Condeelis, J., & Segall, J. E. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1231 · Cited by 929
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
Brown, E., McKee, T., diTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 836 · cited 2×
“The collagen fibers of the lymph node capsule were imaged using second harmonic generation microscopy (34), allowing us to visualize the lymph node capsule and thus localize the tumor cells within the node (Fig.”
MethodSelf-citation
Cited by
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
“These peritumor lymphatics carry fluid, growth factors and cancer cells, and mediate tumor metastases via the lymphatic network ( Figure 2a )”
BackgroundSelf-citationEnhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G., & Jain, R. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.29 · Cited by 2,027
Self-citationLymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,441
“…to increased lymph flow and transport of tumor cells, as well as accommodation of larger tumor cell clusters (Alitalo et al., 2005; He et al., 2005; Hoshida et al., 2006; Ruddell et al., 2008 ) in the sentinel lymph node even before the arrival of the first metastatic cells (Harrell et al., 2007;…”
BackgroundNormalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248
“However, functional lymphatics are absent within tumors in mice (Figs 5A and 5B) and humans.(58,126,132) Our hypothesis is that forces”
BackgroundSelf-citationA Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Metadata
- Authors
- Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y.-L., Pytowski, B., Fukumura, D., Padera, T. P., & Jain, R. K.
- Affiliations
- Harvard University (US)
- 1Edwin L. Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts and
- 2Tumor Biology, ImClone Systems, Inc., New York, New York
- Venue
- Cancer Research
- Published
- 2006-08-15
- Volume
- 66
- Issue
- 16
- Pages
- 8065-8075
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2091324278
- Cited by
- 361
- References
- 47
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 7 · 2023: 13 · 2022: 25 · 2021: 16 · 2020: 21 · 2019: 7 · 2018: 18 · 2017: 13 · 2016: 20 · 2015: 17 · 2014: 23 · 2013: 25 · 2012: 23
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01 CA 85140, T32CA073479, R01CA085140, R01CA096915, R01-CA96915, P01CA080124)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- VEGF-C, lymph node metastasis, VEGFR-3, lymphoid hyperplasia, intravital microscopy, anti-VEGF therapy
- MeSH terms
- Animals, Cell Division, Cell Line, Lymph Nodes, Lymphatic Metastasis, Melanoma, Mice, Inbred C57BL, Mice, Nude, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, In Situ Nick-End Labeling, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor Receptor-3, Vascular Endothelial Growth Factor C, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imaging Steps of Lymphatic Metastasis Reveals That Vascular Endothelial Growth Factor-C Increases Metastasis by Increasing Delivery of Cancer Cells to Lymph Nodes: Therapeutic Implications. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-1392
- The paper
- Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y.-L., Pytowski, B., Fukumura, D., Padera, T. P., & Jain, R. K. (2006). Imaging Steps of Lymphatic Metastasis Reveals That Vascular Endothelial Growth Factor-C Increases Metastasis by Increasing Delivery of Cancer Cells to Lymph Nodes: Therapeutic Implications. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-1392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.